Key stats
About KraneShares MSCI All China Health Care Index ETF
Home page
Inception date
Feb 1, 2018
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
Krane Funds Advisors LLC
Distributor
SEI Investments Distribution Co.
KURE holds all types of publicly-issued shares (including A-shares, B-shares, H-shares, N-shares, P-chips, and Red chips) of large- and mid-cap Chinese companies in the healthcare sector. Stocks must meet minimum trading and liquidity requirements and be classified in the healthcare sector under MSCIs GICS standard. Holdings are market cap-weighted with an adjustment based on the proportion of shares available to foreign investorsexcept for A-shares, which are treated as 100% available. Weights are also modified using a 10/40 capping methodology. Overall, KURE provides exposure to a relatively small slice of the Chinese economy. The index is rebalanced quarterly.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.92%
Health Technology92.30%
Process Industries3.12%
Health Services2.68%
Distribution Services1.82%
Bonds, Cash & Other0.08%
Cash0.08%
Stock breakdown by region
Asia89.45%
Europe9.19%
North America1.36%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
KURE invests in stocks. The fund's major sectors are Health Technology, with 92.30% stocks, and Process Industries, with 3.12% of the basket. The assets are mostly located in the Asia region.
KURE top holdings are BeOne Medicines Ltd. and Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A, occupying 9.19% and 7.75% of the portfolio correspondingly.
KURE last dividends amounted to 0.18 USD. The year before, the issuer paid 0.11 USD in dividends, which shows a 38.54% increase.
KURE assets under management is 92.03 M USD. It's risen 13.45% over the last month.
KURE fund flows account for 35.77 M USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, KURE pays dividends to its holders with the dividend yield of 1.02%. The last dividend (Dec 18, 2024) amounted to 0.18 USD. The dividends are paid annually.
KURE shares are issued by China International Capital Corp. Ltd. under the brand KraneShares. The ETF was launched on Feb 1, 2018, and its management style is Passive.
KURE expense ratio is 0.65% meaning you'd have to pay 0.65% of your investment to help manage the fund.
KURE follows the MSCI China All Shares Health Care 10/40 Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
KURE invests in stocks.
KURE price has risen by 14.81% over the last month, and its yearly performance shows a 23.50% increase. See more dynamics on KURE price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 16.05% over the last month, showed a 15.67% increase in three-month performance and has increased by 26.74% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by 16.05% over the last month, showed a 15.67% increase in three-month performance and has increased by 26.74% in a year.
KURE trades at a premium (0.67%) meaning the ETF is trading at a higher price than the calculated NAV.